Paula Yuri Sacai, Maria Cecília Saccomani Lapa, Rosana Fiorini Puccini, Nívea Nunes Ferraz
Purpose: To evaluate color discrimination in schoolchildren with low birth weight (LBW) and those born full-term and at a weight appropriate for gestational age (AGA).
Methods: LBW children aged 5-11 years and school-, grade-, sex-, and age-matched full-term (birth weight ≥ 2500 g) AGA controls from 14 randomly selected schools from a low-income region were tested. Examinations included visual acuity, ocular motility, and color vision testing using the Farnsworth D-15 test. Color score and interocular color score difference (ICD) were compared between the groups. Multiple logistic regression was used to analyze associations between color vision deficit and group, adjusting for age, sex, visual acuity, strabismus, and amblyopia.
Results: A total of 291 LBW children (age = 8.5 ± 1.3 yrs; 55.7% females) and 265 AGA children (age = 8.5 ± 1.4 yrs; 56.2% females) were examined. Dyschromatopsia was detected in 10.3% of LBW and 7.9% of AGA children, primarily involving tritan and non-specific defects. Color scores were comparable between the groups, and color deficit was significantly associated with younger age and worse visual acuity. The ICD was statistically larger (p = 0.004) in the LBW group, in which the frequencies of strabismus and amblyopia were also higher.
Conclusions: Most LBW children demonstrated normal color discrimination, but their interocular color score difference was larger than that of AGA children.
{"title":"Color Vision in Schoolchildren with Low Birth Weight and Those Born Full-Term with Appropriate Weight for Gestational Age.","authors":"Paula Yuri Sacai, Maria Cecília Saccomani Lapa, Rosana Fiorini Puccini, Nívea Nunes Ferraz","doi":"10.3390/vision9030070","DOIUrl":"10.3390/vision9030070","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate color discrimination in schoolchildren with low birth weight (LBW) and those born full-term and at a weight appropriate for gestational age (AGA).</p><p><strong>Methods: </strong>LBW children aged 5-11 years and school-, grade-, sex-, and age-matched full-term (birth weight ≥ 2500 g) AGA controls from 14 randomly selected schools from a low-income region were tested. Examinations included visual acuity, ocular motility, and color vision testing using the Farnsworth D-15 test. Color score and interocular color score difference (ICD) were compared between the groups. Multiple logistic regression was used to analyze associations between color vision deficit and group, adjusting for age, sex, visual acuity, strabismus, and amblyopia.</p><p><strong>Results: </strong>A total of 291 LBW children (age = 8.5 ± 1.3 yrs; 55.7% females) and 265 AGA children (age = 8.5 ± 1.4 yrs; 56.2% females) were examined. Dyschromatopsia was detected in 10.3% of LBW and 7.9% of AGA children, primarily involving tritan and non-specific defects. Color scores were comparable between the groups, and color deficit was significantly associated with younger age and worse visual acuity. The ICD was statistically larger (<i>p</i> = 0.004) in the LBW group, in which the frequencies of strabismus and amblyopia were also higher.</p><p><strong>Conclusions: </strong>Most LBW children demonstrated normal color discrimination, but their interocular color score difference was larger than that of AGA children.</p>","PeriodicalId":36586,"journal":{"name":"Vision (Switzerland)","volume":"9 3","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12372049/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144972658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rita Donato, Michele Vicovaro, Massimo Nucci, Marco Roccato, Gianluca Campana, Andrea Pavan
This study presents a reanalysis of existing data to clarify how the visual system processes simple dynamic Glass patterns (GPs), with a particular focus on translational configurations. By combining datasets from previous studies, we apply a mixed-effects modeling approach-which offers advantages over the statistical methods used in previous studies-to investigate the contributions of pattern update rate and number of unique frames to perceptual sensitivity. Our findings indicate that the number of unique frames is the most robust predictor of discrimination thresholds, supporting the idea that the visual system integrates global form information across multiple frames-a process consistent with spatiotemporal summation. In contrast, the pattern update rate showed a weaker, though statistically significant, effect. This suggests that faster updates help preserve temporal consistency between frames, facilitating global form extraction. These results align with previous observations on complex dynamic GPs, where discrimination thresholds decrease with more unique frames, suggesting that the summation of form signals across time plays a key role in form-motion perception. By adopting a mixed-effects modeling approach, our reanalysis provides new insights into the mechanisms underlying global form perception in dynamic GPs.
{"title":"Form and Temporal Integration in the Perception of Simple Glass Patterns.","authors":"Rita Donato, Michele Vicovaro, Massimo Nucci, Marco Roccato, Gianluca Campana, Andrea Pavan","doi":"10.3390/vision9030069","DOIUrl":"10.3390/vision9030069","url":null,"abstract":"<p><p>This study presents a reanalysis of existing data to clarify how the visual system processes simple dynamic Glass patterns (GPs), with a particular focus on translational configurations. By combining datasets from previous studies, we apply a mixed-effects modeling approach-which offers advantages over the statistical methods used in previous studies-to investigate the contributions of pattern update rate and number of unique frames to perceptual sensitivity. Our findings indicate that the number of unique frames is the most robust predictor of discrimination thresholds, supporting the idea that the visual system integrates global form information across multiple frames-a process consistent with spatiotemporal summation. In contrast, the pattern update rate showed a weaker, though statistically significant, effect. This suggests that faster updates help preserve temporal consistency between frames, facilitating global form extraction. These results align with previous observations on complex dynamic GPs, where discrimination thresholds decrease with more unique frames, suggesting that the summation of form signals across time plays a key role in form-motion perception. By adopting a mixed-effects modeling approach, our reanalysis provides new insights into the mechanisms underlying global form perception in dynamic GPs.</p>","PeriodicalId":36586,"journal":{"name":"Vision (Switzerland)","volume":"9 3","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12372061/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144972661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Maria Vivas, José Charréu, Bruno Pombo, Tomás Costa, Ana Sofia Lopes, Fernando Trancoso Vaz, Maria João Santos, Isabel Prieto
Combined trabeculectomy-phacoemulsification is known to provoke more inflammation and yield a poorer long-term efficacy than trabeculectomy alone. This study evaluates whether a similar trend exists for Ahmed glaucoma valve implantation when performed with or without concurrent phacoemulsification. We retrospectively analyzed 51 eyes from patients who underwent either Ahmed-Alone (n = 25) or PhacoAhmed (n = 26) surgery over a 5-year period. The primary outcomes included intraocular pressure (IOP), the use of IOP-lowering medications, and the need for further surgical intervention. Absolute success was defined as IOP reduction > 20% and IOP < 21 mmHg without medication; relative success allowed for continued pharmacologic therapy. Both groups showed a significant IOP reduction, with similar final mean IOP values (Ahmed-Alone: 14.02 ± 4.76 mmHg; PhacoAhmed: 13.89 ± 4.17 mmHg; p = 0.99) and comparable reductions in medication use (p = 0.52). Reinterventions occurred less frequently and later in the PhacoAhmed group (12% vs. 27.3%; median time: 27.1 vs. 12 months). Absolute success was not achieved in any PhacoAhmed case but occurred in 9.3% of Ahmed-Alone cases; relative success rates were similar (83.3% vs. 81.4%; p = 0.291). These findings suggest that combining phacoemulsification with Ahmed valve implantation does not significantly alter efficacy or safety profiles. Additional prospective studies are warranted to assess long-term outcomes.
与单纯小梁切除术相比,小梁切除术联合超声乳化术更易引起炎症,远期疗效也较差。本研究评估艾哈迈德青光眼瓣膜植入术是否存在类似的趋势,无论是否同时进行超声乳化术。我们回顾性分析了51只眼,这些患者在5年内分别接受了Ahmed-Alone (n = 25)或PhacoAhmed (n = 26)手术。主要结果包括眼内压(IOP)、降低眼压药物的使用以及进一步手术干预的需要。绝对成功定义为IOP降低20%,IOP < 21 mmHg;相对成功允许继续药物治疗。两组患者的IOP均显著降低,最终平均IOP值相似(Ahmed-Alone: 14.02±4.76 mmHg; PhacoAhmed: 13.89±4.17 mmHg; p = 0.99),药物使用也有类似的降低(p = 0.52)。PhacoAhmed组的再干预发生频率较低,时间较晚(12% vs. 27.3%;中位时间:27.1 vs. 12个月)。没有任何PhacoAhmed病例获得绝对成功,但9.3%的Ahmed-Alone病例获得了绝对成功;相对成功率相似(83.3% vs. 81.4%; p = 0.291)。这些研究结果表明,联合超声乳化术和艾哈迈德瓣膜植入不会显著改变疗效或安全性。需要进一步的前瞻性研究来评估长期结果。
{"title":"Is Combined PhacoAhmed Less Effective than Ahmed Surgery Alone? A 5-Year Retrospective Study of Long-Term Effects.","authors":"Maria Vivas, José Charréu, Bruno Pombo, Tomás Costa, Ana Sofia Lopes, Fernando Trancoso Vaz, Maria João Santos, Isabel Prieto","doi":"10.3390/vision9030068","DOIUrl":"10.3390/vision9030068","url":null,"abstract":"<p><p>Combined trabeculectomy-phacoemulsification is known to provoke more inflammation and yield a poorer long-term efficacy than trabeculectomy alone. This study evaluates whether a similar trend exists for Ahmed glaucoma valve implantation when performed with or without concurrent phacoemulsification. We retrospectively analyzed 51 eyes from patients who underwent either Ahmed-Alone (n = 25) or PhacoAhmed (n = 26) surgery over a 5-year period. The primary outcomes included intraocular pressure (IOP), the use of IOP-lowering medications, and the need for further surgical intervention. Absolute success was defined as IOP reduction > 20% and IOP < 21 mmHg without medication; relative success allowed for continued pharmacologic therapy. Both groups showed a significant IOP reduction, with similar final mean IOP values (Ahmed-Alone: 14.02 ± 4.76 mmHg; PhacoAhmed: 13.89 ± 4.17 mmHg; <i>p</i> = 0.99) and comparable reductions in medication use (<i>p</i> = 0.52). Reinterventions occurred less frequently and later in the PhacoAhmed group (12% vs. 27.3%; median time: 27.1 vs. 12 months). Absolute success was not achieved in any PhacoAhmed case but occurred in 9.3% of Ahmed-Alone cases; relative success rates were similar (83.3% vs. 81.4%; <i>p</i> = 0.291). These findings suggest that combining phacoemulsification with Ahmed valve implantation does not significantly alter efficacy or safety profiles. Additional prospective studies are warranted to assess long-term outcomes.</p>","PeriodicalId":36586,"journal":{"name":"Vision (Switzerland)","volume":"9 3","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12371965/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144972651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
David P Piñero, Ainhoa Molina-Martín, Elena Martínez-Plaza, Kevin J Mena-Guevara, Violeta Gómez-Vicente, Dolores de Fez
Our purpose is to evaluate the binocular contrast sensitivity function (CSF) in a presbyopic population and compare the results obtained with four different simultaneous-vision center-near multifocal contact lens (MCL) designs for distance vision under two illumination conditions. Additionally, chromatic CSF (red-green and blue-yellow) was evaluated. A randomized crossover pilot study was conducted. Four daily disposable lens designs, based on simultaneous-vision and center-near correction, were compared. The achromatic contrast sensitivity function (CSF) was measured binocularly using the CSV1000e test under two lighting conditions: room light on and off. Chromatic CSF was measured using the OptoPad-CSF test. Comparison of achromatic results with room lighting showed a statistically significant difference only for 3 cpd (p = 0.03) between the baseline visit (with spectacles) and all MCLs. Comparison of achromatic results without room lighting showed no statistically significant differences between the baseline and all MCLs for any spatial frequency (p > 0.05 in all cases). Comparison of CSF-T results showed a statistically significant difference only for 4 cpd (p = 0.002). Comparison of CSF-D results showed no statistically significant difference for all frequencies (p > 0.05 in all cases). The MCL designs analyzed provided satisfactory achromatic contrast sensitivity results for distance vision, similar to those obtained with spectacles, with no remarkable differences between designs. Chromatic contrast sensitivity for the red-green and blue-yellow mechanisms revealed some differences from the baseline that should be further investigated in future studies.
{"title":"Contrast Sensitivity Comparison of Daily Simultaneous-Vision Center-Near Multifocal Contact Lenses: A Pilot Study.","authors":"David P Piñero, Ainhoa Molina-Martín, Elena Martínez-Plaza, Kevin J Mena-Guevara, Violeta Gómez-Vicente, Dolores de Fez","doi":"10.3390/vision9030067","DOIUrl":"10.3390/vision9030067","url":null,"abstract":"<p><p>Our purpose is to evaluate the binocular contrast sensitivity function (CSF) in a presbyopic population and compare the results obtained with four different simultaneous-vision center-near multifocal contact lens (MCL) designs for distance vision under two illumination conditions. Additionally, chromatic CSF (red-green and blue-yellow) was evaluated. A randomized crossover pilot study was conducted. Four daily disposable lens designs, based on simultaneous-vision and center-near correction, were compared. The achromatic contrast sensitivity function (CSF) was measured binocularly using the CSV1000e test under two lighting conditions: room light on and off. Chromatic CSF was measured using the OptoPad-CSF test. Comparison of achromatic results with room lighting showed a statistically significant difference only for 3 cpd (<i>p</i> = 0.03) between the baseline visit (with spectacles) and all MCLs. Comparison of achromatic results without room lighting showed no statistically significant differences between the baseline and all MCLs for any spatial frequency (<i>p</i> > 0.05 in all cases). Comparison of CSF-T results showed a statistically significant difference only for 4 cpd (<i>p</i> = 0.002). Comparison of CSF-D results showed no statistically significant difference for all frequencies (<i>p</i> > 0.05 in all cases). The MCL designs analyzed provided satisfactory achromatic contrast sensitivity results for distance vision, similar to those obtained with spectacles, with no remarkable differences between designs. Chromatic contrast sensitivity for the red-green and blue-yellow mechanisms revealed some differences from the baseline that should be further investigated in future studies.</p>","PeriodicalId":36586,"journal":{"name":"Vision (Switzerland)","volume":"9 3","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12372024/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144972691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jolene McCarney, Katie Curran, Tunde Peto, Giuliana Silvestri, Laura N Cushley
People with C3 Dense Deposit Disease (C3DDD), a rare autoimmune disease, often also have ocular complications. Due to the rarity of this disease, there is little known about ocular complications in populations across the world. This paper aimed to assess literature on retinal complications in people with C3 Dense Deposit Disease. A scoping review was conducted and three databases (Embase, Medline All, and Web of Science) were searched using agreed search terms and Boolean operators. All references were imported into Covidence for screening by two reviewers. Any conflicts were resolved by a third reviewer. Data were extracted into an Excel spreadsheet and analysis was conducted using SPSS Version 29. After full text screening, 38 studies were included in the review. These studies were from 1990-2023 and most (67%) being case reports. All studies were conducted in the United States (55%) or Europe (45%). Most studies reported drusen-like deposits in the retina (75%) and retinal pigment epithelial detachment (18%) and macular atrophy (11%). Choroidal Neovascularisation (CNV) was found in 16% of cases. People with C3 Dense Deposit Disease are at risk of ocular complications, primarily drusen-like deposits. Further population-based research and progression is needed.
C3致密沉积病(C3DDD)是一种罕见的自身免疫性疾病,常伴有眼部并发症。由于这种疾病的罕见性,对世界各地人群的眼部并发症知之甚少。本文旨在对C3致密沉积病患者视网膜并发症的文献进行评估。进行了范围审查,并使用商定的搜索条件和布尔运算符搜索了三个数据库(Embase、Medline All和Web of Science)。所有参考文献都导入到covid中,由两名审稿人进行筛选。任何冲突都由第三位审稿人解决。将数据提取到Excel电子表格中,并使用SPSS Version 29进行分析。经过全文筛选,38项研究被纳入综述。这些研究从1990年至2023年进行,大多数(67%)是病例报告。所有研究均在美国(55%)或欧洲(45%)进行。大多数研究报告了视网膜中的毒品样沉积物(75%),视网膜色素上皮脱离(18%)和黄斑萎缩(11%)。16%的病例发现脉络膜新生血管(CNV)。C3致密沉积病患者有眼部并发症的风险,主要是毒品样沉积。需要进一步以人群为基础的研究和进展。
{"title":"The Retinal Complications of C3 Dense Deposit Disease: A Scoping Review.","authors":"Jolene McCarney, Katie Curran, Tunde Peto, Giuliana Silvestri, Laura N Cushley","doi":"10.3390/vision9030064","DOIUrl":"10.3390/vision9030064","url":null,"abstract":"<p><p>People with C3 Dense Deposit Disease (C3DDD), a rare autoimmune disease, often also have ocular complications. Due to the rarity of this disease, there is little known about ocular complications in populations across the world. This paper aimed to assess literature on retinal complications in people with C3 Dense Deposit Disease. A scoping review was conducted and three databases (Embase, Medline All, and Web of Science) were searched using agreed search terms and Boolean operators. All references were imported into Covidence for screening by two reviewers. Any conflicts were resolved by a third reviewer. Data were extracted into an Excel spreadsheet and analysis was conducted using SPSS Version 29. After full text screening, 38 studies were included in the review. These studies were from 1990-2023 and most (67%) being case reports. All studies were conducted in the United States (55%) or Europe (45%). Most studies reported drusen-like deposits in the retina (75%) and retinal pigment epithelial detachment (18%) and macular atrophy (11%). Choroidal Neovascularisation (CNV) was found in 16% of cases. People with C3 Dense Deposit Disease are at risk of ocular complications, primarily drusen-like deposits. Further population-based research and progression is needed.</p>","PeriodicalId":36586,"journal":{"name":"Vision (Switzerland)","volume":"9 3","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12371912/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144972670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Andrea De Cesarei, Virginia Tronelli, Serena Mastria, Vera Ferrari, Maurizio Codispoti
Previous studies observed that emotional scenes, presented as distractors, capture attention and interfere with an ongoing task. This behavioral interference has been shown to be elicited by the semantic rather than by the perceptual properties of a scene, as it resisted the application of low-pass spatial frequency filters. Some studies observed that the visual system can adapt to perceptual conditions; however, little is known concerning whether attentional capture by emotional stimuli can also be modulated by the sequential repetition of viewing conditions or of emotional content. In the present study, we asked participants to perform a parity task while viewing irrelevant natural scenes, which could be either emotional or neutral. These scenes could be either blurred (low-pass filter) or perceptually intact, and the order of presentation was balanced to study the effects of sequential repetition of perceptual conditions. The results indicate that affective modulation was most pronounced when the same viewing condition (either intact or blurred) was repeated, with faster responses when perceptual conditions were repeated for neutral distractors, but to a lesser extent for emotional ones. These data suggest that emotional interference in an attentional task can be modulated by serial sensitization in the processing of spatial frequencies.
{"title":"Behavioral Interference by Emotional Stimuli: Sequential Modulation by Perceptual Conditions but Not by Emotional Primes.","authors":"Andrea De Cesarei, Virginia Tronelli, Serena Mastria, Vera Ferrari, Maurizio Codispoti","doi":"10.3390/vision9030066","DOIUrl":"10.3390/vision9030066","url":null,"abstract":"<p><p>Previous studies observed that emotional scenes, presented as distractors, capture attention and interfere with an ongoing task. This behavioral interference has been shown to be elicited by the semantic rather than by the perceptual properties of a scene, as it resisted the application of low-pass spatial frequency filters. Some studies observed that the visual system can adapt to perceptual conditions; however, little is known concerning whether attentional capture by emotional stimuli can also be modulated by the sequential repetition of viewing conditions or of emotional content. In the present study, we asked participants to perform a parity task while viewing irrelevant natural scenes, which could be either emotional or neutral. These scenes could be either blurred (low-pass filter) or perceptually intact, and the order of presentation was balanced to study the effects of sequential repetition of perceptual conditions. The results indicate that affective modulation was most pronounced when the same viewing condition (either intact or blurred) was repeated, with faster responses when perceptual conditions were repeated for neutral distractors, but to a lesser extent for emotional ones. These data suggest that emotional interference in an attentional task can be modulated by serial sensitization in the processing of spatial frequencies.</p>","PeriodicalId":36586,"journal":{"name":"Vision (Switzerland)","volume":"9 3","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12372086/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144972611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dillan Cunha Amaral, Pedro Lucas Machado Magalhães, Muhammad Alfatih, Bruna Gabriel Miranda, Hashem Abu Serhan, Raíza Jacometti, Bruno Fortaleza de Aquino Ferreira, Letícia Sant'Ana, Diogo Haddad Santos, Mário Luiz Ribeiro Monteiro, Ricardo Noguera Louzada
Obstructive sleep apnea (OSA) is a common condition associated with intermittent hypoxia, systemic inflammation, and vascular dysfunction; mechanisms implicated in retinal disease pathogenesis. This real-world retrospective cohort study used data from the TriNetX Research Network to assess whether continuous positive airway pressure (CPAP) therapy reduces retinal disease incidence among adults with OSA and BMI between 25.0 and 30.0 kg/m2. After 1:1 propensity score matching, 101,754 patients were included in the analysis. Retinal outcomes included diabetic retinopathy (DR), age-related macular degeneration (AMD), retinal vein occlusion (RVO), and central serous chorioretinopathy (CSC). CPAP use was associated with a modest but statistically significant reduction in DR (3.2% vs. 3.4%, RR: 0.922, p = 0.016) and AMD (2.1% vs. 2.3%, RR: 0.906, p = 0.018), while no significant differences were found for RVO or CSC. These findings support prior evidence linking CPAP to improved retinal microvascular health and suggest a protective effect against specific retinal complications. Limitations include a lack of data on CPAP adherence, OSA severity, and imaging confirmation. Still, this study highlights the importance of interdisciplinary care between sleep and eye health, and the need for further prospective studies to validate CPAP's role in preventing retinal disease progression in OSA patients.
阻塞性睡眠呼吸暂停(OSA)是一种与间歇性缺氧、全身性炎症和血管功能障碍相关的常见疾病;视网膜疾病发病机制。这项真实世界的回顾性队列研究使用来自TriNetX研究网络的数据来评估持续气道正压(CPAP)治疗是否能降低BMI在25.0至30.0 kg/m2之间的OSA成人视网膜疾病发病率。经1:1倾向评分匹配后,101754例患者纳入分析。视网膜结局包括糖尿病视网膜病变(DR)、年龄相关性黄斑变性(AMD)、视网膜静脉阻塞(RVO)和中枢性浆液性脉络膜视网膜病变(CSC)。CPAP的使用与DR (3.2% vs. 3.4%, RR: 0.922, p = 0.016)和AMD (2.1% vs. 2.3%, RR: 0.906, p = 0.018)的适度但有统计学意义的降低相关,而RVO或CSC没有显著差异。这些发现支持了CPAP与改善视网膜微血管健康有关的先前证据,并表明CPAP对特定视网膜并发症具有保护作用。局限性包括缺乏CPAP依从性、OSA严重程度和影像学证实的数据。尽管如此,这项研究强调了睡眠和眼睛健康之间跨学科护理的重要性,以及需要进一步的前瞻性研究来验证CPAP在预防OSA患者视网膜疾病进展中的作用。
{"title":"CPAP Use and Retinal Disease Risk in Obstructive Apnea: A Cohort Study.","authors":"Dillan Cunha Amaral, Pedro Lucas Machado Magalhães, Muhammad Alfatih, Bruna Gabriel Miranda, Hashem Abu Serhan, Raíza Jacometti, Bruno Fortaleza de Aquino Ferreira, Letícia Sant'Ana, Diogo Haddad Santos, Mário Luiz Ribeiro Monteiro, Ricardo Noguera Louzada","doi":"10.3390/vision9030065","DOIUrl":"10.3390/vision9030065","url":null,"abstract":"<p><p>Obstructive sleep apnea (OSA) is a common condition associated with intermittent hypoxia, systemic inflammation, and vascular dysfunction; mechanisms implicated in retinal disease pathogenesis. This real-world retrospective cohort study used data from the TriNetX Research Network to assess whether continuous positive airway pressure (CPAP) therapy reduces retinal disease incidence among adults with OSA and BMI between 25.0 and 30.0 kg/m<sup>2</sup>. After 1:1 propensity score matching, 101,754 patients were included in the analysis. Retinal outcomes included diabetic retinopathy (DR), age-related macular degeneration (AMD), retinal vein occlusion (RVO), and central serous chorioretinopathy (CSC). CPAP use was associated with a modest but statistically significant reduction in DR (3.2% vs. 3.4%, RR: 0.922, <i>p</i> = 0.016) and AMD (2.1% vs. 2.3%, RR: 0.906, <i>p</i> = 0.018), while no significant differences were found for RVO or CSC. These findings support prior evidence linking CPAP to improved retinal microvascular health and suggest a protective effect against specific retinal complications. Limitations include a lack of data on CPAP adherence, OSA severity, and imaging confirmation. Still, this study highlights the importance of interdisciplinary care between sleep and eye health, and the need for further prospective studies to validate CPAP's role in preventing retinal disease progression in OSA patients.</p>","PeriodicalId":36586,"journal":{"name":"Vision (Switzerland)","volume":"9 3","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12372019/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144972676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Michael Tsatsos, Efthymia Prousali, Athanasios Karamitsos, Nikolaos Ziakas
This report presents two cases of herpes simplex keratitis recurrence after COVID-19 mRNA vaccination in patients on herpetic prophylaxis due to recurrent herpetic keratitis. A 58-year-old man with a history of a previous penetrating keratoplasty presented with blurred vision and evidence of corneal endothelitis 48 h after the first dose of the m-RNA vaccination, and a 24-year-old male student came with a dendritic ulcer 72 h post first vaccination dose. The original prophylactic treatment of 400 mg of acyclovir twice daily was increased to five times per day for a week for both patients. The grafted patient additionally received an increase in Dexamethasone 0.1% from twice daily to four times a day. Improvement was noted within two days and documented at the weekly review, during which both patients returned to their prophylactic antiviral regime without further recurrence. At the time of their second dose of vaccination, both patients followed the same regime with an increase in treatment as per the first dose of vaccination without recurrence. Our findings suggest that patients with recurrent herpetic disease receiving prophylactic treatment need close monitoring when experiencing even subtle symptoms of recurrence and may benefit from an increase in their dose to therapeutic levels during the first days after the COVID-19 mRNA vaccination.
{"title":"Case Series: Reactivation of Herpetic Keratitis After COVID-19 mRNA Vaccination During Herpetic Prophylaxis.","authors":"Michael Tsatsos, Efthymia Prousali, Athanasios Karamitsos, Nikolaos Ziakas","doi":"10.3390/vision9030063","DOIUrl":"10.3390/vision9030063","url":null,"abstract":"<p><p>This report presents two cases of herpes simplex keratitis recurrence after COVID-19 mRNA vaccination in patients on herpetic prophylaxis due to recurrent herpetic keratitis. A 58-year-old man with a history of a previous penetrating keratoplasty presented with blurred vision and evidence of corneal endothelitis 48 h after the first dose of the m-RNA vaccination, and a 24-year-old male student came with a dendritic ulcer 72 h post first vaccination dose. The original prophylactic treatment of 400 mg of acyclovir twice daily was increased to five times per day for a week for both patients. The grafted patient additionally received an increase in Dexamethasone 0.1% from twice daily to four times a day. Improvement was noted within two days and documented at the weekly review, during which both patients returned to their prophylactic antiviral regime without further recurrence. At the time of their second dose of vaccination, both patients followed the same regime with an increase in treatment as per the first dose of vaccination without recurrence. Our findings suggest that patients with recurrent herpetic disease receiving prophylactic treatment need close monitoring when experiencing even subtle symptoms of recurrence and may benefit from an increase in their dose to therapeutic levels during the first days after the COVID-19 mRNA vaccination.</p>","PeriodicalId":36586,"journal":{"name":"Vision (Switzerland)","volume":"9 3","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12372037/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144972626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mohammed Baker, Kenda Abedal-Kareem, Sadeen Eid, Mahmoud Alkhawaldeh, Yahya Albashaireh, Jihan Joulani, Sara Bani Amer, Ethar Hazaimeh, Omar F Jbarah, Abdelwahab Aleshawi, Rami Al-Dwairi
Background: Congenital insensitivity to pain with anhidrosis (CIPA) is a rare autosomal recessive syndrome caused by loss-of-function mutations in the Neurotrophic Tyrosine Kinase Receptor 1 gene, characterized by recurrent episodes of infections and unexplained fever, anhidrosis, absence of reactions to noxious stimuli, intellectual disability, self-mutilating behaviors, and damage to many body organs, including the eyes. Main text: We systematically searched the Medline/PubMed, Scopus, and Web of Science databases from their inception until March 2025 for papers describing the clinical manifestations of patients with CIPA. The inclusion criterion was papers reporting ocular manifestations of patients diagnosed with CIPA. We excluded non-English papers or those reporting ocular manifestations of patients diagnosed with syndromes other than CIPA. Also, we excluded review articles, clinical trials, gray literature, or any paper that did not report ocular manifestations of patients with CIPA or that reported patients with previous ocular surgeries. Out of 6243 studies, 28 were included in the final analysis, comprising 118 patients. The mean age was 7.37 years, and males represented 63.5% (n = 75). Of the patients, fifty-six had bilateral ocular manifestations. The most common ocular manifestations were the absence of corneal reflex in 56 patients (47.5%, bilateral in 56), whereas corneal ulcerations were the second most common manifestation in 46 patients (38.98%, bilateral in 8), followed by corneal opacity in 32 patients (27.11%, bilateral in 19). Topical lubricants, topical antibiotics, and lateral tarsorrhaphy were common management modalities for these patients. Absent corneal sensitivity, corneal ulcers, and corneal opacities, among other manifestations, are common ocular presentations in patients with CIPA. Conclusions: Self-mutilation, intellectual disability, decreased lacrimation, and absence of the corneal reflex are factors that may explain the development of these manifestations in CIPA. The early detection of these manifestations can improve patient conditions and prevent further complications, in addition to helping to guide the clinical diagnosis of CIPA in these patients.
背景:先天性无汗性疼痛不敏感(CIPA)是一种罕见的常染色体隐性综合征,由神经营养型酪氨酸激酶受体1基因的功能缺失突变引起,其特征是反复发作的感染和不明原因的发热、无汗、对有害刺激没有反应、智力残疾、自残行为以及包括眼睛在内的许多身体器官的损伤。我们系统地检索了Medline/PubMed、Scopus和Web of Science数据库,从其建立到2025年3月,检索了描述CIPA患者临床表现的论文。纳入标准为报道CIPA患者眼部表现的论文。我们排除了非英文论文或那些报道被诊断为非CIPA综合征的患者眼部表现的论文。此外,我们排除了综述性文章、临床试验、灰色文献或任何没有报道CIPA患者眼部表现或报道既往眼部手术患者的论文。在6243项研究中,有28项纳入最终分析,包括118名患者。平均年龄7.37岁,男性占63.5% (n = 75)。56例患者有双侧眼部表现。56例(47.5%,56例双侧)患者最常见的眼部表现是角膜反射缺失,其次是角膜溃疡,46例(38.98%,8例双侧),其次是角膜混浊32例(27.11%,19例双侧)。局部润滑剂、局部抗生素和外侧鼻塞修补术是这些患者常见的治疗方式。缺乏角膜敏感性、角膜溃疡和角膜混浊等表现是CIPA患者常见的眼部表现。结论:自残、智力残疾、流泪减少和角膜反射缺失可能是CIPA患者出现这些症状的原因。这些表现的早期发现可以改善患者的病情,防止进一步的并发症,并有助于指导这些患者CIPA的临床诊断。
{"title":"Ocular Manifestations in Congenital Insensitivity to Pain with Anhidrosis: A Window into a Rare Syndrome.","authors":"Mohammed Baker, Kenda Abedal-Kareem, Sadeen Eid, Mahmoud Alkhawaldeh, Yahya Albashaireh, Jihan Joulani, Sara Bani Amer, Ethar Hazaimeh, Omar F Jbarah, Abdelwahab Aleshawi, Rami Al-Dwairi","doi":"10.3390/vision9030062","DOIUrl":"10.3390/vision9030062","url":null,"abstract":"<p><p><b>Background</b>: Congenital insensitivity to pain with anhidrosis (CIPA) is a rare autosomal recessive syndrome caused by loss-of-function mutations in the Neurotrophic Tyrosine Kinase Receptor 1 gene, characterized by recurrent episodes of infections and unexplained fever, anhidrosis, absence of reactions to noxious stimuli, intellectual disability, self-mutilating behaviors, and damage to many body organs, including the eyes. <b>Main text</b>: We systematically searched the Medline/PubMed, Scopus, and Web of Science databases from their inception until March 2025 for papers describing the clinical manifestations of patients with CIPA. The inclusion criterion was papers reporting ocular manifestations of patients diagnosed with CIPA. We excluded non-English papers or those reporting ocular manifestations of patients diagnosed with syndromes other than CIPA. Also, we excluded review articles, clinical trials, gray literature, or any paper that did not report ocular manifestations of patients with CIPA or that reported patients with previous ocular surgeries. Out of 6243 studies, 28 were included in the final analysis, comprising 118 patients. The mean age was 7.37 years, and males represented 63.5% (n = 75). Of the patients, fifty-six had bilateral ocular manifestations. The most common ocular manifestations were the absence of corneal reflex in 56 patients (47.5%, bilateral in 56), whereas corneal ulcerations were the second most common manifestation in 46 patients (38.98%, bilateral in 8), followed by corneal opacity in 32 patients (27.11%, bilateral in 19). Topical lubricants, topical antibiotics, and lateral tarsorrhaphy were common management modalities for these patients. Absent corneal sensitivity, corneal ulcers, and corneal opacities, among other manifestations, are common ocular presentations in patients with CIPA. <b>Conclusions</b>: Self-mutilation, intellectual disability, decreased lacrimation, and absence of the corneal reflex are factors that may explain the development of these manifestations in CIPA. The early detection of these manifestations can improve patient conditions and prevent further complications, in addition to helping to guide the clinical diagnosis of CIPA in these patients.</p>","PeriodicalId":36586,"journal":{"name":"Vision (Switzerland)","volume":"9 3","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12286263/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144699747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mitchell Shultz, Zachary M Vest, Valerie Trubnik, Steven R Sarkisian, Dana M Hornbeak
This multicenter study evaluated the effectiveness and safety of third-generation trabecular micro-bypass implantation (iStent® infinite) combined with phacoemulsification (n = 233 eyes). Key outcomes through 12 months included the mean change in intraocular pressure (IOP) and the number of topical medications, as well as proportions achieving IOPs ≤ 18/15/12 mmHg or using 0/1/2/ ≥ 3 medications. In all eyes with 12-month follow-up data (n = 96, consistent cohort), the mean IOP reduced from 17.2 ± 4.2 mmHg preoperatively to 13.8 ± 3.0 mmHg at Month 12 (p = 0.001), while the mean number of medications reduced from 1.24 ± 0.91 preoperatively to 0.61 ± 0.96 at Month 12 (p = 0.001). The proportions of eyes achieving IOP ≤ 18/15/12 mmHg increased from 63.5%, 34.4%, and 14.6% preoperatively to 92.7%, 71.9%, and 37.5%, respectively at Month 12, (all p = 0.001). The proportions of eyes off medication increased from 16.7% preoperatively to 62.5% at Month 12 (p = 0.001). This study provides clinically relevant, real-world results that demonstrate significant reductions in IOP and the number of topical glaucoma medications required following iStent infinite trabecular micro-bypass and phacoemulsification.
{"title":"Third-Generation Trabecular Micro-Bypass Implantation and Phacoemulsification in Patients with Glaucoma: A Multicenter Study.","authors":"Mitchell Shultz, Zachary M Vest, Valerie Trubnik, Steven R Sarkisian, Dana M Hornbeak","doi":"10.3390/vision9030061","DOIUrl":"10.3390/vision9030061","url":null,"abstract":"<p><p>This multicenter study evaluated the effectiveness and safety of third-generation trabecular micro-bypass implantation (iStent<sup>®</sup> infinite) combined with phacoemulsification (n = 233 eyes). Key outcomes through 12 months included the mean change in intraocular pressure (IOP) and the number of topical medications, as well as proportions achieving IOPs ≤ 18/15/12 mmHg or using 0/1/2/ ≥ 3 medications. In all eyes with 12-month follow-up data (n = 96, consistent cohort), the mean IOP reduced from 17.2 ± 4.2 mmHg preoperatively to 13.8 ± 3.0 mmHg at Month 12 (<i>p</i> = 0.001), while the mean number of medications reduced from 1.24 ± 0.91 preoperatively to 0.61 ± 0.96 at Month 12 (<i>p</i> = 0.001). The proportions of eyes achieving IOP ≤ 18/15/12 mmHg increased from 63.5%, 34.4%, and 14.6% preoperatively to 92.7%, 71.9%, and 37.5%, respectively at Month 12, (all <i>p</i> = 0.001). The proportions of eyes off medication increased from 16.7% preoperatively to 62.5% at Month 12 (<i>p</i> = 0.001). This study provides clinically relevant, real-world results that demonstrate significant reductions in IOP and the number of topical glaucoma medications required following iStent infinite trabecular micro-bypass and phacoemulsification.</p>","PeriodicalId":36586,"journal":{"name":"Vision (Switzerland)","volume":"9 3","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12286079/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144699750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}